Skip to main content
    B

    Biofrontera Inc. Warrants (BFRIW)

    Official site

    DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $0.00
    +0.00 (+0.00%)

    Last updated: Nov 02, 2026 at 4:00 PM ET

    Earnings

    Upcoming Estimates

    Results pendingPeriod ending Jun 30, 2026
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    $9.50M
    Range$9.00M - $10.00M
    2 analysts
    Results pendingPeriod ending Sep 30, 2026
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    $8.25M
    Range$8.00M - $8.50M
    2 analysts
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    Date TBD
    -N/AN/A-----
    Sep 26EST
    Date TBD
    -N/AN/A-----
    Jun 26EST
    Date TBD
    -N/AN/A-----
    Mar 21
    Reported Jun 30
    -$0.46N/AN/A-----
    Dec 20
    Reported Mar 31
    -$0.44N/AN/A-----
    Sep 20
    Reported Dec 31
    -$0.20N/AN/A-----
    Jun 20
    Reported Sep 30
    -$0.20N/AN/A-----

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-13.80%Operating Margin-4.37%
    ROE-988.00%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    Beta0.96Avg VolumeN/A
    52-Week High$0.1552-Week Low$0.00

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 90.2% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 19.5, below 30, the oversold line.

    Moving Averages

    SMA 10$0.00
    SMA 20$0.01
    SMA 50$0.01
    SMA 200$0.03
    EMA 10$0.00
    EMA 20$0.01
    EMA 50$0.01
    EMA 200$0.04

    MACD

    Line: -0.00Signal: -0.00Hist: 0.00

    ADX

    ADX: 40.0+DI: 22.0-DI: 59.5

    Aroon & PSAR

    Aroon Up16.0
    Aroon Down84.0
    PSAR$0.00

    Bollinger Bands

    Upper Band$0.01
    Lower Band$-0.00
    %B Position25270%(Upper)
    Band Width0.22

    RSI (14-Day)

    Oversold
    19.5

    Momentum Oscillators

    Stoch %K2.1
    Stoch %D2.0
    Williams %R-97.9
    ROC (10d)-73.1%
    Momentum-0.00
    CCI (20d)-118.7
    MFI (14d)17.5

    Volatility Measures

    ATR (14d)$0.00(73.6%)
    StdDev (20d)0.00
    Hist Vol254.6%(High)

    Volume Flow

    VWAP$0.00
    OBV-241.0K
    AD Line-249.8K
    CMF (20d)0.157

    Volume Metrics

    Avg Vol (20d)9.4K
    Vol RatioN/A
    VWMA (20d)$0.00

    Pivot Points

    R3$0.00
    R2$0.00
    R1$0.00
    Pivot Point$0.00
    S1$0.00
    S2$0.00
    S3$0.00

    Advanced Oscillators

    TSI-54.56
    Ultimate Osc16.1
    KST-777.45

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about BFRIW

    News

    No news available

    Company news will appear here when available

    BFRIW Profitability: Margins, ROIC and FCF

    Biofrontera Inc. Warrants (BFRIW) has an operating margin of -4.4% and a net margin of -13.8%.

    Operating margin
    -4.4%
    Net margin
    -13.8%
    ROE
    -988.0%
    BFRIW financial statements

    Biofrontera Inc. Warrants Competitors

    The companies most similar to Biofrontera Inc. Warrants (BFRIW) include Azitra, Dermata Therapeutics and Arcutis Biotherapeutics.

    Sector: Healthcare

    BFRIW Bull Case vs Bear Case

    Bull case

    • BFRIW grew quarterly revenue 32.9% year over year.

    Bear case

    • BFRIW has a -13.8% net profit margin.

    Updated Aug 15, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.